Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial-Reference-Cited by-同舟云学术

Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

Published:2019-03-18 Issue:1 Volume:18 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Galletti Ferruccio^ORCID,Fazio Valeria,Gentile Marco,Schillaci Giuseppe,Pucci Giacomo,Battista Francesca,Mercurio Valentina,Bosso Giorgio,Bonaduce Domenico,Brambilla Nadia,Vitalini Cristina,D’Amato Massimo,Giacovelli Giampaolo

Funder

Rottapharm|Madaus

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12944-019-1002-y.pdf

Reference33 articles.

1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9.

2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardio- vascular disease mortality in middle-aged men. JAMA. 2002;288:2709–16.

3. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec cardiovascular study. Circulation. 1997;95:69–75.